EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia

Eva Crespo-García, Carlos Quero-Dotor, Aleix Noguera-Castells iD, Laia Sancho-Vila, Laura Martinez-Verbo iD, Manel Esteller iD

British Journal of Haematology · 2026

DOI: 10.1111/bjh.70339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Eva Crespo-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain. Hauptthemen laut MEDLINE: Sulfonamides, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Peptide Initiation Factors. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia, The Agencia Estatal de Investigacion, Spain, Cellex Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We show how the loss of activity of the translation initiation factor EIF5A2-either through gene hypermethylation or pharmacologic inhibition of its highly specific hypusine post-translational modification-induces venetoclax sensitivity in acute myeloid leukaemia (AML) cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesBridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcutePeptide Initiation FactorsRNA-Binding ProteinsEpigenesis, GeneticGene SilencingAntineoplastic AgentsHumansEukaryotic Translation Initiation Factor 5ADNA MethylationCell Line, TumorDrug Resistance, Neoplasm

Stichwörter der Autor:innen

DNA methylationEpigeneticsacute myeloid leukemiavenetoclax

Substanzen

SulfonamidesBridged Bicyclo Compounds, HeterocyclicvenetoclaxEukaryotic Translation Initiation Factor 5APeptide Initiation FactorsRNA-Binding ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
  • Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
  • Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Barcelona, Spain.
  • Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
  • Cancer Epigenetics Group, Sant Pau Research Institute (IRSantPau), Barcelona, Spain.

ORCID-Profile: Aleix Noguera-Castells, Laura Martinez-Verbo, Manel Esteller

Förderung

  • Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia
  • The Agencia Estatal de Investigacion, Spain
  • Cellex Foundation
  • 'la Caixa' Foundation
  • Ministry of Science, Innovation and Universities, Spain
  • Fundación Cellex

Zitieren

APA

Crespo-García, E., Quero-Dotor, C., Noguera-Castells, A., Sancho-Vila, L., Martinez-Verbo, L., & Esteller, M. (2026). Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.70339

Vancouver

Crespo-García E, Quero-Dotor C, Noguera-Castells A, Sancho-Vila L, Martinez-Verbo L, Esteller M. Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia. British Journal of Haematology. 2026. doi:10.1111/bjh.70339

BibTeX
@article{CrespoGarca2026,
  author = {Crespo-García, Eva and Quero-Dotor, Carlos and Noguera-Castells, Aleix and Sancho-Vila, Laia and Martinez-Verbo, Laura and Esteller, Manel},
  title = {Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70339}
}
Kostenlos starten →